# Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)

> **NCT00605657** · PHASE1,PHASE2 · COMPLETED · sponsor: **Koneti Rao** · enrollment: 6 (actual)

## Conditions studied

- ALPS
- Hypersplenism
- Lymphadenopathy

## Interventions

- **DRUG:** Valproic Acid
- **PROCEDURE:** CT Scan
- **PROCEDURE:** Blood Sample

## Key facts

- **NCT ID:** NCT00605657
- **Lead sponsor:** Koneti Rao
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2013-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00605657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00605657, "Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00605657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*